Jing Liu, MD, PhD
Titles
Associate Professor of Department of Infectious Diseases
Committee member of Infectious Disease Society, Guangdong Preventive Medicine Association
Research Interests
Liver injury and liver regeneration
Natural history of HBV and HCV infection and anti-virus therapy
B cellular immunity of Hepatitis C
Education and Experience
Education
2010-2013 MD, PhD, the Sun Yat-sen University, thesis: “B cellular immunity of Hepatitis C”.
2004-2007 Master, the Sun Yat-sen University, thesis: “Natural History of HBV infection : Spontaneous decrease of HBV DNA”.
1994-1999 Bachelor, Medical School of Nanchang University.
Experience
2014-present Associate Professor, Department of Infectious Diseases, the 3rd Affiliated Hospital of Sun Yat-sen University
2014-2015 Visiting Scholar, Feinberg Medical School of Northwestern University, US, thesis: “Liver injury and liver regeneration”.
2009-2014 Attending Doctor, Department of Infectious Diseases, the 3rd Affiliated Hospital of Sun Yat-sen University
2007-2009 Residency, Department of Infectious Diseases, the 3rd Affiliated Hospital of Sun Yat-sen University
1999-2004 Residency, Department of Infectious Diseases, Infectious Diseases Hospital of Nanchang.
Honor and Award
The Excellent Graduate Students Prize of the Sun Yat-sen University, China, 2012
Publications
1. Jing Liu#, Zi-de Deng*, Yue Wu, Jun-qiang Xie, Liang Peng, Zhi-liang Gao. The epidemiological features of spontaneous decrease of HBV DNA level in CHB/LC patients. Chin J Infect Dis, 2009, 27(4):228-233.
2. Jing Liu#, Chao-shuang Lin, San-hong Hu, Mei-ling Liang, Zhi-xin Zhao, Zhi-liang Gao*. Quality of life in patients with chronic hepatitis C after PEG-Interferon a-2a therapy. Chin J Hepatol, 2011, 19(12):890-893.
3. Jing Liu#, Chao-shuang Lin#, Wei-qiang Gan, Yu-bao Zheng, Zhi-liang Gao*. Effect of healthcare insurance policy on the quality of life of chronic hepatitis C patients receiving interferon α-2a plus ribavirin therapy. Experimental and Therapeutic Medicine, 2012, 3: 1062-1066.
4. Jing Liu#, Ting Liu, Yuan-kai Wu, Wei-min Ke, Zi-de Deng*, Zhi-liang Gao. Dynamic change of hepatitis B surface antigen expression in chronic hepatitis B patients during the natural recovery course and the short-term antivirus treatment. Chin J Hepatol, 2013, 21(8):575-579.
5. Jing Liu#, Zhen Xu, Wen-Xiong Xu, Zhi-Shuo Mo, Xiang Zhu, Zhi-Liang Gao*. Role of BAFF/BLyS in Prediction of Rapid Virological Response to PEG-IFN α-2a plus Ribavirin in Patients with Chronic Hepatitis C. Hepatology, 2013(Supplement): Epub ahead of print.
6. Jing Liu#, Zhe-bin Wu, Zhi-shuo Mo, Qing-Xian Cai, Xiang Zhu, Zhi-Liang Gao*. B-lymphocyte stimulator (BLys) and HCV genotype or IL28B SNPs for prediction of rapid virologic response in patients with chronic hepatitis C. Journal of Hepatology, 2013(Supplement), 58: S349.
7. Jing Liu#, Qing-Xian Cai, Xiang Zhu, Zhi-shuo Mo, Zhe-bin Wu, Zhi-Liang Gao*. B activating factor (BAFF) and IFNγor IP10 for prediction of rapid virological response in patients with chronic hepatitis C. Journal of Hepatology, 2013(Supplement), 58: S349.
8. Liang Peng#, Jing Liu#, Yang-mei Li#, Zhan-Lian Huang, Pei-pei Wang, Yu-rong Gu, Yu-bao Zheng and Zhi-liang Gao*. Serum proteomics analysis and comparisons using Itraq in the progression of hepatitis B. Experimental and Therapeutic Medicine, 2013, 6: 1169-1176.
9. Jian Zhang#, Jing Liu#, Yong Liu, Weibin Wu, Xiaojun Li, Yonghui Wu, Huiguo Chen, Kai Zhang, Lijia Gu*. miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12. Biomedicine & Pharmacotherapy 74(2015):215-221.
10. Jian Zhang#, Jing Liu#, Jianning Chen, Xiaojun Li, Yonghui Wu, Huiguo Chen, Weibin Wu, Kai Zhang, Lijia Gu*. Angiotensin receptor blockers (ARBs) reduce the risk of lung cancer: a systematic review and meta-analysis. Int J Clin Exp Med 2015;8(8):12656-12660.
11. Liang Peng#, Jing Liu#, Yang-mei Li#, Zhan-lian Huang, Pei-pei Wang, Yu-bao Zheng, Yun-peng Hua, Zhi-liang Gao*. iTRAQ-based proteomic analysis of hepatic tissues from patients with HBV-induced acute on chronic liver failure. Experimental and Therapeutic Medicine, 2015, 10: 1732-1742.
Note: # Co-first author, * Corresponding author
Contact
Department of Infectious Diseases
The 3rd Affiliated Hospital of Sun Yat-sen University
600, Tianhe Road, Guangzhou, China
Phone: 86-20-85252372
Mobil Phone: 86-13556051920
Fax: 86-20-85252250
